Skip to content

Sprint Quattro Secure MRI™ SureScan™ 6947M55 (UDI 00763000180317)Recalls & reported problems

Medtronic, Inc. · LEAD 6947M55 MRI US DF4 RCMCRD · Class 3 · Implant

All models of Medtronic Sprint Quattro Lead (67) · Sprint Quattro Secure MRI SureScan (6)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00763000180317), received between Jul 6, 2026 and Sep 29, 2026 — classified as 1 injury, 1 malfunction.

The most frequently reported specific device problem is “Over-Sensing” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 1 reportsAug 2026: 0 reportsSep 2026: 1 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1
  • Over-Sensing1

Patient problems

  • Erythema1
  • No Clinical Signs, Symptoms or Conditions1
  • Unspecified Infection1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • MalfunctionSep 29, 2026Over-Sensing

    It was reported that the Right Ventricular (RV) lead exhibited T-Wave Oversensing (TWOS) noted on the current electrogram (EGM). The lead remains in use. No patient complications have been reported as a result of this event.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50935060 ↗
  • InjuryJul 6, 2026Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT THE CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D) SYSTEM WAS REMOVED DUE TO INFECTION WITH REDNESS NOTED. NO FURTHER PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.

    Patient problems: Erythema; Unspecified Infection

    MAUDE report 25721448 ↗

Other permanent pacemaker Electrode devices

All permanent pacemaker Electrode devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page